Exceptional Response to Copanlisib in a Heavily Pretreated Patient With
PIK3CA
-Mutated Metastatic Breast Cancer
JCO Precis Oncol
.
2020 Nov:4:335-340.
doi: 10.1200/PO.19.00049.
Authors
Nikolaos Spathas
1
,
Panagiota Economopoulou
1
,
Ioannis Kotsantis
1
,
Nikolaos Oikonomopoulos
1
,
Amanda Psyrri
1
Affiliation
1
Attikon University Hospital, Athens, Greece.
PMID:
35050736
DOI:
10.1200/PO.19.00049
No abstract available